Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The center is only ordering ten patches per order. What's the deal?-reconranger
ZERO FOLLOW THRU JUST BROKEN PROMISES. WHY TRUST DID GUY!-reconranger
Jan 18, 2017 Premier Biomedical Pain Management Solutions Announces Product Distribution Agreement of Their Superior Pain Relief Products
Press Release
Dec 15, 2016 Premier Biomedical, Inc. CEO Letter - December, 2017
Press Release
Dec 6, 2016 Premier Biomedicals Research on its Patent Pending Anti-Cancer Treatment With Metronomic Chemotherapy Recognized for Publication in the Prestigious British Journal of Cancer
Press Release
Nov 16, 2016 Premier Biomedical Pain Management Solutions Reports Outstanding Results in Pre-Production Pain Patch Trials Conducted by Medical Professionals
Press Release
Nov 9, 2016 Premier Biomedical Pain Management Solutions Executives Advance Plans for an Array of Opioid-Free New Products to Compete in $112 Billion Global Pain Market Beginning January 2017
Press Release
Oct 6, 2016 Premier Biomedical, Inc. CEO Letter, October 2016 - Quarterly Corporate Update
Press Release
Sep 27, 2016 Premier Biomedical Pain Management Solutions Announces Shipment of Initial Samples of Opioid-Free, 50-State Legal, CBD-Based Pain-Relieving Topical Patch
Press Release
Sep 15, 2016 Premier Biomedical and Advanced Technologies Solutions Form Pain Management Joint Venture to Treat Generalized, Neuropathic and Localized Pain With Natural Cannabis-Based Products
Press Release
Aug 22, 2016 Premier Biomedical Appoints Dr. Patricio Reyes to Board and Chief Technical Officer
Press Release
Aug 1, 2016 Premier Biomedical and Advanced Technologies Solutions Agree to Forming Joint Venture in Pain Management, Treating Neuropathic and Localized Pain
Press Release
Jul 18, 2016 Premier Biomedical, Inc. CEO Letter, July, 2016 Updates and Progress on Partnership Initiatives for Specialty Diseases and Anti-Cancer Drugs Research
Press Release
Jul 6, 2016 Premier Biomedical Anti-Cancer Antibody Outperforms Leading Multi-Billion Dollar Commercial Cancer Treatments in Initial Head-to-Head Testing at a Major University
Press Release
May 31, 2016 Premier Biomedical Confirms Consolidation of Debt
Press Release
May 24, 2016 Premier Biomedical Announces the Appointment of Dr. James Frincke to Chief Technical Officer Position
Press Release
Apr 11, 2016 Premier Biomedical, Inc. Cancer Immunotherapy Research Highlights to Be Presented at AACR Conference
Press Release
Mar 16, 2016 Premier Biomedical, Inc. Engages Agent to Identify Suitable Joint Venture Partners in China and Europe
Press Release
Mar 8, 2016 Premier Biomedical, Inc. Engages Agent in India to Identify Suitable Joint Venture Partners in Asia
Press Release
Feb 25, 2016 Zika Virus Suspected To Be Transmitted Sexually; Premier Biomedical Inc. Increases Focus; Optimistic Their Patented Extracorporeal Methodology Could Be Most Effective Treatment
Press Release
Feb 16, 2016 Premier Biomedical Inc. Optimistic Their Patented Methodology Will Be Effective In Treating Dengue and Zika Virus
Press Release
Feb 8, 2016 Premier Biomedical, Inc. Releases Video "A Scientific Roadmap to Cure Cancer"
Press Release
Feb 1, 2016 Premier Biomedical Announces Intended $6 Million Investment by Brazilian Joint Venture Partner, Auramedi, to Manufacture, Market and Distribute Premier’s New Technology Products
Press Release
Jan 26, 2016 Premier Biomedical Files Provisional Patent Application on Second Drug to Treat Fibromyalgia, Neuropathic Pain, MS Symptoms, and Alcohol and Chemical Addiction
Press Release
Jan 19, 2016 Premier Biomedical CEO in Radio Interview Discusses Core Technology, Immunotherapy, Neuropathy Medication and Planned Series of Joint Ventures in Brazil, Asia and Europe for 2016
Press Release
Jan 11, 2016 Broad-Based Patent Involving Innovative Extracorporeal Treatment Therapy Issued – Premier Biomedical Believes This Could Lead To Cancer Cure
Press Release
Jan 5, 2016 Premier Biomedical Announces $1.6mil Financing – Consolidates Funding Needs Through 2016
Press Release
Dec 15, 2015 Premier Biomedical Recognized for Huge Growth Potential
Press Release
Dec 8, 2015 Scientist Working With Premier Biomedical Invited To Present Possible Breakthrough Findings on Chemotherapy Treatment at San Antonio Breast Cancer Symposium Educational Session
Press Release
Nov 16, 2015 Premier Biomedical Receives Notice of Allowance on Broad Base Patent Involving Innovative Extracorporeal Treatment Therapy – Premier Believes This May Lead To Cancer Cure
Press Release
Oct 15, 2015 Premier Biomedical and Auramedi Farmacêutica Agree to Explore Forming Joint Venture in Brazil
Press Release
Sep 29, 2015 Premier Biomedical, Inc. Accomplishments and Recent News
Press Release
Aug 25, 2015 Premier Biomedical Announces the Addition of Drs. Carl and Kathryn Meyer to Scientific Advisory Board
Press Release
Aug 24, 2015 "New To The Street" Announces Upcoming Interviews With 6 New Clients & 5 Recurring Clients
Press Release
Aug 20, 2015 Premier Biomedical, Inc. Files Patent Application on Cockayne Syndrome Treatment, Which Could Potentially Lead to Major Breakthroughs Against Parkinson's Disease, Alzheimer's Disease and Aging
Press Release
Aug 19, 2015 Premier Biomedical Announces the Addition of Dr. James Frincke to Scientific Advisory Board
Press Release
Jul 28, 2015 Premier Biomedical, Inc. Signs Deal with Consultant Team in Brazil to Arrange Possible JV Partnerships for Growth
Press Release
Jul 16, 2015 "New To The Street" Announces Upcoming Episodes in Top 2 Markets and Line-Up for Its July & August Shoots
Press Release
Jul 13, 2015 Premier Biomedical Announces the Addition of Dr. Ryan C. Fields to Scientific Advisory Board
Press Release
Apr 30, 2015 OTC Markets Group Welcomes Newly Verified OTCQB Companies – April 30
Announcement
What's the status on this promise
On July 3, 2015, we entered into a Consulting Agreement dated June 23, 2015, with FBROCCO ASSESSORIA EMPRES ARIAL LTDA ASSESSORIA EMPRESARIAL LTDA, a Brazilian company ("FBROCCO"), pursuant to which FBROCCO will provide certain consulting services to us, which shall include (i) developing a relationship between us and a Brazilian-based entity that is interested in entering into a joint venture where the purpose is to import, market and sell our products in Brazil and other South American countries; and (ii) facilitating a trip for William Hartman, one of our officers and directors, to travel to Brazil and meet with the proposed joint venture partner and various governmental officials who have relationships that would be advantageous to the formation and success of the anticipated joint venture.
We agreed to pay FBROCCO Ten Thousand Dollars ($10,000) for facilitating Mr. Hartman's trip to Brazil and will issue a total of 1,500,000 shares of our common stock to FBROCCO if a successful joint venture is formed and generates One Million U.S. Dollars ($1,000,000) in gross revenues by June 23, 2016. The Consulting Agreement was finalized on July 3, 2015, the day an executed version of the agreement was delivered to us by FBROCCO.
BIEI need an investor relation campaign. We are loaded ready to selling to new buyers. Hartass make it happen.-reconranger
Premier Biomedical ( (BIEI)
0.0055 ? -0.00012 (-2.14%)
Volume: 14,135,419
No one mention trails?- reconranger
We shall see till waiting on the cancer cure super vitamin. How about the answer for ZIKA virus.-reconranger
I sound like Hartass with all his broken promises. This is a sub-penny stock because of terrible leadership!-reconranger
Same old broken record!- reconranger
DILUTION and no new investors.- reconranger
Awesome close let's roll boys-reconranger
Ok, let's do it turn a profit-reconranger
Awesome - reconranger
This would truly help this company that is still trading sub penny ten years later- reconranger
Key word PROFITS.- reconranger
LOL, do you not agree the company need to have a positive quarter of profits?-reconranger
Get use to being at this level. Need at least 3 good quarters of profits.-reconranger
Bounding over watch. Wedge formation-reconranger
Rise Up Falcons-reconranger
All together until it's time to sell. Let's keep it real fellows. Don't be the last one out! We eat our own in penny world.-reconranger
Let that be the excuse!- reconranger
How about contacting Hartass to setup a meeting with share holders via Webinar/Skype.- reconranger
Awesome how can I help -reconranger
Like the old saying. You get what you pay for. In this case cheap @ss Hartass paid for trash!-reconranger
Awesome keep up the outstanding work buddy.-reconranger
Looking for a red close Friday.-reconranger
The Dangers Of Share Dilution-reconranger
http://www.investopedia.com/articles/stocks/11/dangers-of-stock-dilution.asp
How do you know that dilution ends next week? -reconranger
Totally missing a huge opportunity. Hartass stop being cheap! The website launch was huge news for BIEI. Why not PR it correctly? Unreal leadership - reconranger
Bleeding out slowly-reconranger
Awesome recap want be long now. Go SFOR and Falcons- reconranger
Ok awesome if you say so buddy-reconranger
Hope so, only time will tell. GLTY -reconranger
Friday will be the day.-reconranger
Agree, Hartass you have a solid core group of investors. Time for you to produce.-reconranger